Suppr超能文献

小分子抑制剂诱导 Aurora A 的 DFG 翻转的新机制。

A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A.

机构信息

Drug Discovery Department, Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, United States.

出版信息

ACS Chem Biol. 2012 Apr 20;7(4):698-706. doi: 10.1021/cb200508b. Epub 2012 Jan 27.

Abstract

Most protein kinases share a DFG (Asp-Phe-Gly) motif in the ATP site that can assume two distinct conformations, the active DFG-in and the inactive DFG-out states. Small molecule inhibitors able to induce the DFG-out state have received considerable attention in kinase drug discovery. Using a typical DFG-in inhibitor scaffold of Aurora A, a kinase involved in the regulation of cell division, we found that halogen and nitrile substituents directed at the N-terminally flanking residue Ala273 induced global conformational changes in the enzyme, leading to DFG-out inhibitors that are among the most potent Aurora A inhibitors reported to date. The data suggest an unprecedented mechanism of action, in which induced-dipole forces along the Ala273 side chain alter the charge distribution of the DFG backbone, allowing the DFG to unwind. As the ADFG sequence and three-dimensional structure is highly conserved, DFG-out inhibitors of other kinases may be designed by specifically targeting the flanking alanine residue with electric dipoles.

摘要

大多数蛋白激酶在 ATP 结合位点共享一个 DFG(天冬氨酸-苯丙氨酸-甘氨酸)基序,该基序可以呈现两种截然不同的构象,即活性的 DFG-in 和非活性的 DFG-out 状态。能够诱导 DFG-out 状态的小分子抑制剂在激酶药物发现中受到了广泛关注。我们使用 Aurora A(一种参与细胞分裂调节的激酶)的典型 DFG-in 抑制剂骨架,发现针对 N 端侧翼残基 Ala273 的卤素和腈取代基诱导了酶的全局构象变化,导致 DFG-out 抑制剂成为迄今为止报道的最有效的 Aurora A 抑制剂之一。这些数据表明了一种前所未有的作用机制,其中沿 Ala273 侧链的诱导偶极力改变了 DFG 骨架的电荷分布,从而使 DFG 解旋。由于 ADFG 序列和三维结构高度保守,因此可以通过用偶极子特异性靶向侧翼丙氨酸残基来设计其他激酶的 DFG-out 抑制剂。

相似文献

5
Structure of mitogen-activated protein kinase kinase 1 in the DFG-out conformation.无丝分裂原活化蛋白激酶激酶 1 在 DFG -out 构象下的结构。
Acta Crystallogr F Struct Biol Commun. 2021 Dec 1;77(Pt 12):459-464. doi: 10.1107/S2053230X21011687. Epub 2021 Nov 25.
8
9
Type II Inhibitors Targeting CDK2.靶向细胞周期蛋白依赖性激酶2的II型抑制剂。
ACS Chem Biol. 2015 Sep 18;10(9):2116-25. doi: 10.1021/acschembio.5b00398. Epub 2015 Jul 20.

引用本文的文献

本文引用的文献

2
Update on Aurora Kinase Targeted Therapeutics in Oncology.肿瘤学中极光激酶靶向治疗的最新进展
Expert Opin Drug Discov. 2011 Mar;6(3):291-307. doi: 10.1517/17460441.2011.555395.
8
Discovery of a potential allosteric ligand binding site in CDK2.发现 CDK2 中的一个潜在别构配体结合位点。
ACS Chem Biol. 2011 May 20;6(5):492-501. doi: 10.1021/cb100410m. Epub 2011 Feb 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验